Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 681012, 8 pages
http://dx.doi.org/10.1155/2015/681012
Research Article

Biological Production of an Integrin αvβ3 Targeting Imaging Probe and Functional Verification

1Department of Nuclear Medicine, Kyungpook National University School of Medicine, 50 Samduk-dong 2-ga, Jung Gu, Daegu 700-721, Republic of Korea
2Department of Biochemistry and Cell Biology, Kyungpook National University School of Medicine, Daegu 700-842, Republic of Korea

Received 14 July 2014; Revised 30 October 2014; Accepted 30 October 2014

Academic Editor: Dominic Fan

Copyright © 2015 Mi-Hye Hwang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Carmeliet and R. K. Jain, “Angiogenesis in cancer and other diseases,” Nature, vol. 407, no. 6801, pp. 249–257, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. I. Dijkgraaf, A. J. Beer, and H.-J. Wester, “Application of RGD-containing peptides as imaging probes for alphavbeta3 expression,” Frontiers in Bioscience, vol. 14, no. 3, pp. 887–899, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. K. Jain, “Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy,” Science, vol. 307, no. 5706, pp. 58–62, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. F. Shojaei, “Anti-angiogenesis therapy in cancer: current challenges and future perspectives,” Cancer Letters, vol. 320, no. 2, pp. 130–137, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. P. C. Brooks, R. A. F. Clark, and D. A. Cheresh, “Requirement of vascular integrin αvβ3 for angiogenesis,” Science, vol. 264, no. 5158, pp. 569–571, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Cai, S. Sam Gambhir, and X. Chen, “Multimodality tumor imaging targeting integrin alphavbeta3,” BioTechniques, vol. 39, no. 6, pp. S14–S25, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. F. Azam, S. Mehta, and A. L. Harris, “Mechanisms of resistance to antiangiogenesis therapy,” European Journal of Cancer, vol. 46, no. 8, pp. 1323–1332, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. N. P. Vadhan, C. E. Myers, E. Rubin, D. Shohamy, R. W. Foltin, and M. A. Gluck, “Stimulus-response learning in long-term cocaine users: acquired equivalence and probabilistic category learning,” Drug and Alcohol Dependence, vol. 93, no. 1-2, pp. 155–162, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. E. Badr, J. W. Hewett, X. O. Breakefield, and B. A. Tannous, “A highly sensitive assay for monitoring the secretory pathway and ER stress,” PLoS ONE, vol. 2, no. 6, article e571, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. J. Folkman, “Angiogenesis in cancer, vascular, rheumatoid and other disease,” Nature Medicine, vol. 1, no. 1, pp. 27–31, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Hanahan and R. A. Weinberg, “The hallmarks of cancer,” Cell, vol. 100, no. 1, pp. 57–70, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Cai, J. Rao, S. S. Gambhir, and X. Chen, “How molecular imaging is speeding up antiangiogenic drug development,” Molecular Cancer Therapeutics, vol. 5, no. 11, pp. 2624–2633, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. K. Hodivala-Dilke, “αvβ3 integrin and angiogenesis: a moody integrin in a changing environment,” Current Opinion in Cell Biology, vol. 20, no. 5, pp. 514–519, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. P. ten Dijke, M.-J. Goumans, and E. Pardali, “Endoglin in angiogenesis and vascular diseases,” Angiogenesis, vol. 11, no. 1, pp. 79–89, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. N. Ferrara, “Vascular endothelial growth factor: basic science and clinical progress,” Endocrine Reviews, vol. 25, no. 4, pp. 581–611, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. G. H. Mahabeleshwar, J. Chen, W. Feng, P. R. Somanath, O. V. Razorenova, and T. V. Byzova, “Integrin affinity modulation in angiogenesis,” Cell Cycle, vol. 7, no. 3, pp. 335–347, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. P. Xiong, T. Stehle, B. Diefenbach et al., “Crystal structure of the extracettutar segment of integrin αVβ3,” Science, vol. 294, no. 5541, pp. 339–345, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. R. Auerbach, R. Lewis, B. Shinners, L. Kubai, and N. Akhtar, “Angiogenesis assays: a critical overview,” Clinical Chemistry, vol. 49, no. 1, pp. 32–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Kerbel and J. Folkman, “Clinical translation of angiogenesis inhibitors,” Nature Reviews Cancer, vol. 2, no. 10, pp. 727–739, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. W. J. M. Mulder, D. W. J. van der Schaft, P. A. I. Hautvast et al., “Early in vivo assessment of angiostatic therapy efficacy by molecular MRI,” FASEB Journal, vol. 21, no. 2, pp. 378–383, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. C. Zhang, M. Jugold, E. C. Woenne et al., “Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner,” Cancer Research, vol. 67, no. 4, pp. 1555–1562, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. R. Haubner, H. J. Wester, W. A. Weber et al., “Noninvasive imaging of αvβ3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography,” Cancer Research, vol. 61, no. 5, pp. 1781–1785, 2001. View at Google Scholar · View at Scopus
  23. J.-H. Yan, G.-W. Yang, J.-P. Wang, N. Wu, and G.-H. Zhuang, “Gene expression and activities analysis of a new fusion protein (RGD) 3/tTF,” Chinese Journal of Biotechnology, vol. 23, no. 3, pp. 409–413, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Bhaumik and S. S. Gambhir, “Optical imaging of Renilla luciferase reporter gene expression in living mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 377–382, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus